Eli Lilly and Company (NYSE: LLY) announced the completion of its acquisition of Centessa Pharmaceuticals plc (LSE: 0ACX), a clinical-stage ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions